HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population‐based cohort study

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jbmr.1874PMID 23362011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Epidemiology of osteoporosis and osteoporotic fractures].

  2014cited by this paper
• Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

  2012cited by this paper
• HIV and aging--preparing for the challenges ahead.

  2012cited by this paper
• “Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study”

  2012cited by this paper
• Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.

  2012cited by this paper
• Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study

  2012cited by this paper
• Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

  2011cited by this paper
• Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

  2011cited by this paper
• Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans

  2011cited by this paper
• Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP).

  2011cited by this paper
• Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

  2009cited by this paper
• Continuous antiretroviral therapy decreases bone mineral density

  2009cited by this paper
• Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

  2009cited by this paper
• Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults

  2009cited by this paper
• Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

  2008cited by this paper
• Risk of subsequent fracture after low-trauma fracture in men and women.

  2007cited by this paper
• Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study

  2007cited by this paper
• Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

  2007cited by this paper
• Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

  2006cited by this paper
• Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

  2001cited by this paper
• Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

  2000cited by this paper
• Epidemiology of osteoporosis and osteoporotic fractures.

  1985cited by this paper

• Incidence of frailty-related fracture among Medicaid beneficiaries living with HIV and cancer: A cohort study

  2025cites this paper
• Use of Potentially Inappropriate Medication and Association with Falls During Hospitalisation: An Analysis Based on Electronic Health Records (POLAR_MI project).

  2025cites this paper
• Narrative Review on the Management of Neck of Femur Fractures in People Living with HIV: Challenges, Complications, and Long-Term Outcomes

  2025cites this paper
• Bone Loss and Fractures in Post-Menopausal Women Living with HIV: A Narrative Review

  2024cites this paper
• Impaired Bone Tissue Quality Associated with Inflammation in HIV-Immunological Non-Responders: A Cross-Sectional Analysis.

  2024cites this paper
• Performance of a modified fracture risk assessment tool for fragility fracture prediction among older veterans living with HIV

  2023cites this paper
• Combined effects of smoking and HIV infection on the occurrence of aging-related manifestations

  2023cites this paper
• Changes in bone quality after switching from a TDF to a TAF based ART: A pilot randomized study

  2023cites this paper
• HIV and fracture: Risk, assessment and intervention

  2023cites this paper
• IL-27 Modulates the Cytokine Secretion in the T Cell–Osteoclast Crosstalk During HIV Infection

  2022cites this paper
• Factors associated to neurocognitive impairment in older adults living with HIV

  2022cites this paper
• Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional study

  2022cites this paper
• The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study

  2022cites this paper
• An Abnormal Inflammatory Pattern Associated with Long-Term Non-Progression of HIV Infection Impacts Negatively on Bone Quality

  2022cites this paper
• Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study.

  2022cites this paper
• Validation of a six-item dietary calcium screening tool among HIV patients in China

  2021cites this paper
• Trabecular bone score and 3D-DXA in young, antiretroviral treatment-naïve patients in Madrid

  2021cites this paper
• A global analysis of literature on older adults and lifelong living with HIV

  2021cites this paper
• Worldwide relative smoking prevalence among people living with and without HIV

  2021cites this paper
• Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model.

  2021cites this paper
• People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis

  2021cites this paper
• The management of displaced femoral neck fractures: a narrative review

  2021cites this paper
• Muscle mass, strength, bone mineral density and vascular function in middle-aged people living with HIV vs. age-matched and older controls

  2021cites this paper
• Effects of exercise training on bone mineral density in adults living with HIV: a retrospective study

  2021cites this paper
• Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors

  2020cites this paper
• Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults

  2020cites this paper
• Vitamin-D Status and Relationship with Bone-Fragility-Fractures in HIV-InfectedPatients: CaseControl Study

  2020cites this paper
• The Prevalence of Osteoporosis in Hiv Infected Patient and its Correlation with Cd4 Count/Clinical Staging in Indian Population

  2020cites this paper
• Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study

  2020cites this paper
• Osteoporosis and periodontal diseases with HIV infection (review)

  2020cites this paper
• Bone density, microarchitecture and tissue quality after 1 year of treatment with dolutegravir/abacavir/lamivudine.

  2020cites this paper
• Use of Bisphosphonates, Calcium and Vitamin D for Bone Demineralization in Patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials

  2020cites this paper
• Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors

  2020influential citation
• Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study

  2020cites this paper
• People living with HIV and fracture risk

  2020cites this paper
• HIV Infection, HIV Therapy, and Bone Health

  2020cites this paper
• Inflammation status in HIV-positive individuals correlates with changes in bone tissue quality after initiation of ART

  2019cites this paper
• HIV infection is associated with low bone quality, independently of bone mineral density

  2019cites this paper
• Treatment of Human Immunodeficiency Virus Infection With Tenofovir Disoproxil Fumarate–Containing Antiretrovirals Maintains Low Bone Formation Rate, But Increases Osteoid Volume on Bone Histomorphometry

  2019cites this paper
• Time domain, near-infrared diffuse optical methods for path length resolved, non-invasive measurement of deep-tissue blood flow

  2019cites this paper
• Drugs Causing Bone Loss.

  2019cites this paper
• Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case–Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4)

  2019cites this paper
• Older HIV-infected adults: complex patients—comorbidity (I)

  2019cites this paper
• Secondary Osteoporosis

  2019cites this paper
• Bone mineral status and renal tubular dysfunction in HIV-positive men

  2018cites this paper
• Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age

  2018cites this paper
• Understanding mechanisms to promote successful aging in persons living with HIV.

  2018cites this paper
• Ageing with HIV

  2018cites this paper
• Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate

  2018cites this paper
• Chronic kidney disease, cardiovascular disease, and osteoporotic fractures in patients with and without HIV in the US Veteran’s Affairs Administration System

  2018cites this paper
• Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise

  2018cites this paper
• The Hidden Burden of Fractures in People Living With HIV

  2018cites this paper
• Comparative study of antiretroviral drug regimens and drug–drug interactions between younger and older HIV-infected patients at a tertiary care teaching hospital in South Korea

  2018cites this paper
• Vitamin D Status and the Relationship with Bone Fragility Fractures in HIV-Infected Patients: A Case Control Study

  2018cites this paper
• High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

  2018cites this paper
• Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence

  2018cites this paper
• Premature Spinal Bone Loss in Women Living with HIV is Associated with Shorter Leukocyte Telomere Length

  2018cites this paper
• A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population

  2018cites this paper
• HIV, antiretroviral therapy, pregnancy, lactation and bone health in Uganda

  2018cites this paper
• Use of drugs for osteoporosis treatment in patients with type 2 diabetes mellitus : population-based cohort study

  2017cites this paper
• Bone Loss in HIV Infection

  2017cites this paper
• Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

  2017cites this paper
• Bone and the Immune System

  2017cites this paper
• Emphysema is associated with thoracic vertebral bone attenuation on chest CT scan in HIV-infected individuals

  2017cites this paper
• Validation of fragility fractures in primary care electronic medical records: A population-based study.

  2017cites this paper
• Novel imaging modalities for the comparison of bone microarchitecture among HIV+ patients with and without fractures: a pilot study

  2017cites this paper
• Infection after fracture osteosynthesis – Part I

  2017cites this paper
• Bone Toxicology

  2017cites this paper
• Bone health in HIV and hepatitis B or C infections

  2017cites this paper
• Changes in Bone Mineral Density, Body Composition, Vitamin D Status, and Mineral Metabolism in Urban HIV‐Positive South African Women Over 12 Months

  2017cites this paper
• Clinical experience with microindentation in vivo in humans.

  2017cites this paper
• An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV− men

  2017cites this paper
• Title Infection after fracture osteosynthesis – Part I : Pathogenesis , diagnosis and classification

  2017cites this paper
• 104 – Issues in the Aging HIV-Positive Patient

  2017cites this paper
• Evaluación de la afectación ósea en el paciente infectado por el virus de la inmunodeficiencia humana

  2017cites this paper
• Metaboliczne choroby kości u pacjentów zakażonych HIV

  2017cites this paper
• Factors associated with fractures in HIV-infected persons: which factors matter?

  2016cites this paper
• The protease inhibitors and HIV-associated bone loss

  2016cites this paper
• Management of bone mineral density in HIV-infected patients

  2016cites this paper
• Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study

  2016cites this paper
• Physiological and pathophysiological bone turnover — role of the immune system

  2016cites this paper
• Update on Pediatric Human Immunodeficiency Virus Infection: Paradigms in Treatment and Prevention.

  2016cites this paper
• Brief Report: HIV Infection Is Associated With Worse Bone Material Properties, Independently of Bone Mineral Density

  2016cites this paper
• HIV infection and bone disease

  2016cites this paper
• Perspectives on menopause and women with HIv

  2016cites this paper
• Bone health and HIV in resource-limited settings: a scoping review

  2016cites this paper
• Bone Biomarkers in HIV

  2016cites this paper
• Which HIV patients should be screened for osteoporosis: an international perspective

  2016cites this paper
• British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015

  2016cites this paper
• HIV and Orthopaedics: Musculoskeletal Manifestations and Outcomes.

  2016cites this paper
• Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.

  2015cites this paper
• Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient

  2015cites this paper
• Does HIV Infection Increase the Risk of Perioperative Complications After THA? A Nationwide Database Study

  2015cites this paper
• Does HIV Infection Increase the Risk of Short-Term Adverse Outcomes Following Total Knee Arthroplasty?

  2015cites this paper
• AN OVERVIEW OF BONE DISEASE IN HIV-INFECTED PATIENTS

  2015cites this paper
• Role of T cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss

  2015cites this paper
• Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study

  2015cites this paper
• Skeletal health in adults with HIV infection.

  2015cites this paper
• Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients

  2015cites this paper
• HIV infection and osteoporosis.

  2015cites this paper